Back to top
more

Bausch Health (BHC)

(Real Time Quote from BATS)

$8.74 USD

8.74
762,165

+0.12 (1.39%)

Updated Apr 26, 2024 02:25 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (174 out of 252)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for BHC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Bausch Health Cos Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 962 591 2,119 1,816 3,244
Receivables 1,998 1,790 1,775 1,577 1,839
Notes Receivable 0 0 0 0 0
Inventories 1,544 1,090 993 1,094 1,107
Other Current Assets 1,092 776 720 855 779
Total Current Assets 5,596 4,247 5,607 5,342 6,969
Net Property & Equipment 1,707 1,600 1,598 1,567 1,466
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 2,101 2,166 2,252 2,137 1,690
Intangibles 17,639 17,347 19,405 21,489 23,327
Deposits & Other Assets 307 326 340 664 411
Total Assets 27,350 25,686 29,202 31,199 33,863
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 719 521 407 337 503
Current Portion Long-Term Debt 450 432 0 0 1,234
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3,133 2,988 4,791 4,576 4,511
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 4,302 3,941 5,198 4,913 6,248
Mortgages 0 0 0 0 0
Deferred Taxes/Income 163 202 529 528 705
Convertible Debt 0 0 0 0 0
Long-Term Debt 21,938 20,334 22,654 23,925 24,661
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,029 949 855 1,228 1,113
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 27,432 25,426 29,236 30,594 32,727
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,423 10,391 10,317 10,227 10,172
Capital Surplus 214 159 462 454 429
Retained Earnings -9,778 -9,186 -8,961 -8,013 -7,452
Other Equity -941 -1,104 -1,852 -2,063 -2,013
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -82 260 -34 605 1,136
Total Liabilities & Shareholder's Equity 27,350 25,686 29,202 31,199 33,863
Total Common Equity -82 260 -34 605 1,136
Shares Outstanding 360.90 361.90 359.40 355.40 352.50
Book Value Per Share -0.23 0.72 -0.09 1.70 3.22

Fiscal Year End for Bausch Health Cos Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 962 780 588 531
Receivables NA 1,998 1,948 1,743 1,688
Notes Receivable NA 0 0 0 0
Inventories NA 1,544 1,272 1,240 1,222
Other Current Assets NA 1,092 1,048 890 796
Total Current Assets NA 5,596 5,048 4,461 4,237
Net Property & Equipment NA 1,707 1,584 1,599 1,596
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 2,101 2,189 2,191 2,163
Intangibles NA 17,639 17,915 16,927 17,131
Deposits & Other Assets NA 307 328 325 318
Total Assets NA 27,350 27,064 25,503 25,445
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 719 569 515 561
Current Portion Long-Term Debt NA 450 536 444 446
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 3,133 3,119 3,008 2,916
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 4,302 4,224 3,967 3,923
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 163 213 215 205
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 21,938 21,894 20,108 20,207
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 968 942 965
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 27,432 27,299 25,232 25,300
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 10,423 10,420 10,412 10,405
Capital Surplus NA 214 190 188 171
Retained Earnings NA -9,778 -9,739 -9,361 -9,387
Other Equity NA -941 -1,106 -968 -1,044
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA -82 -235 271 145
Total Liabilities & Shareholder's Equity NA 27,350 27,064 25,503 25,445
Total Common Equity 0 -82 -235 271 145
Shares Outstanding 365.40 360.90 365.20 364.30 362.00
Book Value Per Share 0.00 -0.23 -0.64 0.74 0.40